Pain Management Multi-Site PA Cleared In 36 Hours Across 9 Sites
This outsourced prior authorization case study covers a 9-site pain management group with 38 providers that was running interventional procedure PA, opioid step therapy, and MRI imaging PA on three different workflows. Denials were unpredictable, peer-to-peer requests piled up, and the medical director was personally signing off on every long-acting opioid PA after hours. After moving prior authorization to Staffingly’s dedicated remote team, a HIPAA-compliant healthcare BPO with named specialists, not a shared offshore pool, turnaround dropped to under 36 hours, first-pass approvals hit 82%, and denial overturn on appeal climbed to 67%. The model handles controlled substance documentation, MRI and imaging PA, and procedure authorization in one integrated pod.
See Your Pain Management PA Backlog Cleared in 2 Weeks
Free assessment, no obligation, no high-pressure pitch.
What happens when pain management prior authorization is handled in-house without dedicated outsourcing?
Pain management is one of the heaviest prior authorization workloads in outpatient medicine because the workflow splits across three very different payer pathways: interventional procedures, controlled substance PAs, and MRI and advanced imaging PAs. The practice in this composite case study, 38 providers across 9 sites, was carrying all three burdens on legacy workflows with no clean handoff, and one medical director absorbing the overflow.
For pain management, the per-provider PA volume runs higher than the AMA average because almost every procedure and every controlled substance refill carries a PA touchpoint. Three failure modes kept repeating.
Fragmented procedure PA
Epidural steroid injections, radiofrequency ablation, and spinal cord stimulator trials each required detailed conservative-therapy documentation, assembled on a separate legacy workflow with no clean handoff between sites.
Controlled-substance bottleneck
Long-acting opioid PAs required step therapy history, PDMP review, and frequently a medical director signature, documentation that must hold up under DEA and state pharmacy board review. The medical director was personally writing every long-acting opioid PA letter on weekends because no one else had a process they trusted.
RBM denials and P2P backlog
MRI and advanced imaging PAs flow through radiology benefit managers with their own appropriate-use criteria, so the denial mix ran heavier on imaging and procedure PAs than national averages would suggest. Peer-to-peer scheduling backed up to 10 days behind real-time demand, delaying procedures and pushing patients onto higher opioid doses while they waited.
Financial and regulatory exposure: KFF’s 2024 analysis showed Medicare Advantage plans denied 7.7% of 53 million PA requests, with rates varying from 4.2% at Elevance to 12.8% at UnitedHealthcare. CMS-0057-F adds further pressure: starting January 1, 2026, impacted payers must decide standard PAs within 7 calendar days and expedited within 72 hours, with the Provider Access API live January 1, 2027, deadlines the practice’s three fragmented in-house workflows could not reliably meet.
How does outsourced prior authorization work for a multi-site pain management group?
Staffingly built a unified pain management PA pod that handles all three workflows in a single dedicated team. The pod is staffed with licensed clinical reviewers trained on interventional pain, controlled substance documentation, and radiology benefit manager appropriate-use criteria, plus virtual coordinators who run portals, faxes, and peer-to-peer scheduling across the 9 sites.
Tri-track intake
Every order routes to one of three tracks: Procedure PA captures conservative therapy history, imaging findings, and ICD-10 mapping. Controlled Substance PA pulls PDMP data, prior failed therapies, and pain scores, with the long-acting opioid sub-track flagged for medical director sign-off only when state or payer rules require it. Imaging PA routes through the relevant RBM with appropriate-use criteria pre-mapped.
RBM-specific payer playbooks
Most pain management denials are not commercial payer decisions; they are RBM decisions on imaging and procedures. The pod maintains a living rulebook on AIM, eviCore, HealthHelp, and other major RBMs, including appropriate-use criteria, peer-to-peer reviewer specialties, and known approval patterns by ICD-10 and CPT.
Centralized P2P desk
One coordinator owns a single calendar across all 38 providers and 9 sites, books peer-to-peer slots within 48 hours of denial, and pre-loads each physician with a denial brief covering the payer reviewer specialty, the RBM criteria cited, prior successful overturns on similar denials, and the imaging or chart evidence that supports approval.
The fourth lever was controlled substance documentation discipline. Every long-acting opioid PA gets a standardized packet that includes PDMP screenshots, prior failed therapy documentation, urine drug screen results within payer-required windows, pain scale trends, and the conservative therapy timeline. The medical director still signs off, but only after the packet is complete and reviewed by the clinical lead.
Compliance posture: HIPAA · SOC 2 Type II · ISO 27001 · HITRUST · BAA signed at onboarding. PHI never leaves the practice’s EHR environment. The dedicated, remote team works inside the practice’s own systems under role-based access, not a shared offshore pool.
What moved across 9 sites and 38 providers
Industry benchmarks from AMA 2024 PA Survey, KFF 2024 Medicare Advantage data, and CAQH 2024 Index. Staffingly results are composite outcomes across 3 multi-site pain management engagements.
| Metric | Industry Benchmark | Staffingly Result | Improvement |
|---|---|---|---|
| Procedure + imaging PA turnaround | 5 to 10 business days (AMA) | Under 36 hours | 75%+ faster |
| First-pass approval rate | 55 to 70% typical | 82% | +12 to +27 pts |
| Denial overturn on appeal | 50 to 60% industry, 80.7% MA when appealed (KFF) | 67% | Repeatable |
| Peer-to-peer scheduled within 48h | 30 to 50% typical | 94% | Backlog eliminated |
| Provider hours saved per week | 0 baseline | 8 to 10 hours | Reclaimed for clinic |
| Cost per PA vs in-house | $10.92 manual (CAQH 2024) | 55 to 60% lower | Margin reinvested |
How does outsourcing pain management prior authorization change the numbers?
Conservative model: 39 PAs/provider/week (AMA 2024) · $10.92 manual cost per PA (CAQH 2024) · Staffingly team rate $349/week. Run it with your numbers →
inside 48 hours of denial
vs in-house (55-60% range)
reclaimed per week (8-10 range)
approval rate (benchmark 55-70%)
What separates us from typical vendors
We don't name competitors. Ask your current vendor for proof of all four certifications. We will wait.
| Capability | Typical Vendor | Staffingly |
|---|---|---|
| Certification Stack | HIPAA training only | HIPAA + SOC 2 Type II + ISO 27001 + HITRUST |
| Clinical Credentials | General virtual assistants | Overseas-licensed MDs, RNs, PharmDs, billers |
| Risk-Free Pilot | No trial period | 2-Week Risk-Free Pilot, full refund if not satisfied |
| Pricing Transparency | Quote-only, hidden setup fees | $399/wk single, $349/wk team, $299/wk dept |
| Workflow Coverage | Procedure PA only or imaging PA only | Procedure + Controlled Substance + Imaging in one pod |
Where AI carries the clerical load, and where licensed humans hold the controlled-substance line
Pain management is a workflow where AI can compress most clerical work, but anything tied to controlled substances must stay with credentialed humans. Here is the split:
What AI handles. Payer portal navigation and form pre-fill, RBM appropriate-use criteria mapping, ICD-10 and CPT lookup, prior denial pattern recognition across the last 12 months, conservative therapy timeline assembly from EHR notes, peer-to-peer slot routing across 9 sites, and CMS-0057-F deadline tracking by payer. The system also pulls PDMP data into the controlled substance packet so coordinators do not retype it.
What licensed humans still own. Every clinical narrative on a controlled substance PA. The decision to pursue an appeal vs route to a covered alternative. Peer-to-peer execution. Medical director sign-off on long-acting opioids. Communication with prescribing providers when an RBM denial requires additional imaging or functional documentation. The clinical reviewers are licensed MDs and RNs trained on pain management workflows.
The AMA 2024 survey found 61% of physicians worry AI is being used by payers to increase denials. Staffingly's pain management pod uses AI strictly to compress the clerical work that consumes 13 hours per physician per week. Controlled substance decisions, peer-to-peer execution, and appeals strategy stay with credentialed humans accountable to your medical director, operating under HIPAA, SOC 2 Type II, ISO 27001, and HITRUST controls.
Questions practice operators ask before signing
Staffingly charges a flat per-specialist weekly fee, $399/week for one dedicated remote PA specialist, $349/week for five or more (volume), and $299/week for ten or more (enterprise). There is no percentage of collections, no percentage of revenue recovered, and no per-authorization fee. The outsourcing model is designed for practices that want predictable costs and a dedicated, HIPAA-compliant team rather than a shared offshore pool or a software subscription that still requires in-house staff to run it.
Outsource the workflow behind this result
Stop losing procedure days to peer-to-peer backlogs
Run a 2-week risk-free pilot on your real backlog. We work all three PA tracks in parallel, hit the CMS-0057-F clock, and your medical director stops writing letters on weekends.
